Offering Circular & EGM of Shareholders

Offering Circular and EGM

DSM and Firmenich have jointly launched the exchange offer to DSM shareholders as part of a merger of equals to create DSM-Firmenich.

The Managing Board and Supervisory Board of DSM and the Board of Directors of Firmenich unanimously support the offer. Firmenich shareholders have already approved the transactions to establish DSM-Firmenich.

An Extraordinary General Meeting of DSM shareholders will be held on Monday 23 January 2023, at which DSM shareholders will be requested to vote to approve, amongst other things, the transactions that will result in a new, dynamic creation and innovation partner in nutrition, beauty and well-being.

The number of outstanding shares on 22 November 2022, the convocation date, was 217,095,579.

More information, including recordings of webcasts to investors and media, plus all the documents associated with this transaction are available at www.creator-innovator.com.

Investor webcast

DSM and Firmenich held a joint webcast for analysts and investors on Tuesday 22 November to provide an update on the progress of the merger made so far.

Extraordinary General Meeting

The EGM for DSM shareholders will be held in Heerlen in the Netherlands.   Shareholders are invited to attend in-person or virtually. DSM will observe all applicable Covid-19 rules and regulations at its premises throughout the event.

Details of how to join will be provided closer to the day.